These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3027369)

  • 1. A single-base change within the DNA polymerase locus of herpes simplex virus type 2 can confer resistance to aphidicolin.
    Tsurumi T; Maeno K; Nishiyama Y
    J Virol; 1987 Feb; 61(2):388-94. PubMed ID: 3027369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single mutations at many sites within the DNA polymerase locus of herpes simplex viruses can confer hypersensitivity to aphidicolin and resistance to phosphonoacetic acid.
    Honess RW; Purifoy DJ; Young D; Gopal R; Cammack N; O'Hare P
    J Gen Virol; 1984 Jan; 65 ( Pt 1)():1-17. PubMed ID: 6319564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of an aphidicolin-resistant mutant of herpes simplex virus type 2 which induces an altered viral DNA polymerase.
    Nishiyama Y; Suzuki S; Yamauchi M; Maeno K; Yoshida S
    Virology; 1984 May; 135(1):87-96. PubMed ID: 6328755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the herpes simplex virus DNA polymerase gene conferring hypersensitivity to aphidicolin.
    Coen DM; Furman PA; Aschman DP; Schaffer PA
    Nucleic Acids Res; 1983 Aug; 11(15):5287-97. PubMed ID: 6308578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aphidicolin resistance in herpes simplex virus type I reveals features of the DNA polymerase dNTP binding site.
    Hall JD; Wang YS; Pierpont J; Berlin MS; Rundlett SE; Woodward S
    Nucleic Acids Res; 1989 Nov; 17(22):9231-44. PubMed ID: 2555788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the herpes simplex virus major DNA-binding protein gene leading to altered sensitivity to DNA polymerase inhibitors.
    Chiou HC; Weller SK; Coen DM
    Virology; 1985 Sep; 145(2):213-26. PubMed ID: 2992151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro mutagenesis of the herpes simplex virus type 1 DNA polymerase gene results in altered drug sensitivity of the enzyme.
    Matthews JT; Carroll RD; Stevens JT; Haffey ML
    J Virol; 1989 Nov; 63(11):4913-8. PubMed ID: 2552170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aphidicolin resistance in herpes simplex virus type 1 appears to alter substrate specificity in the DNA polymerase.
    Hall JD; Woodward S
    J Virol; 1989 Jun; 63(6):2874-6. PubMed ID: 2542598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic characterization of the vaccinia virus DNA polymerase: identification of point mutations conferring altered drug sensitivities and reduced fidelity.
    Taddie JA; Traktman P
    J Virol; 1991 Feb; 65(2):869-79. PubMed ID: 1898973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in the herpes simplex virus DNA polymerase gene can confer resistance to 9-beta-D-arabinofuranosyladenine.
    Coen DM; Furman PA; Gelep PT; Schaffer PA
    J Virol; 1982 Mar; 41(3):909-18. PubMed ID: 6284981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical mapping of drug resistance mutations defines an active center of the herpes simplex virus DNA polymerase enzyme.
    Knopf KW; Kaufman ER; Crumpacker C
    J Virol; 1981 Sep; 39(3):746-57. PubMed ID: 6270349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fine mapping and molecular cloning of mutations in the herpes simplex virus DNA polymerase locus.
    Coen DM; Aschman DP; Gelep PT; Retondo MJ; Weller SK; Schaffer PA
    J Virol; 1984 Jan; 49(1):236-47. PubMed ID: 6317891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resistance of herpes simplex virus to 9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]guanine: physical mapping of drug synergism within the viral DNA polymerase locus.
    Crumpacker CS; Kowalsky PN; Oliver SA; Schnipper LE; Field AK
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1556-60. PubMed ID: 6324203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Hwang CB; Ruffner KL; Coen DM
    J Virol; 1992 Mar; 66(3):1774-6. PubMed ID: 1310779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of DNA polymerase alpha in host cell reactivation of UV-irradiated herpes simplex virus.
    Nishiyama Y; Yoshida S; Maeno K
    J Virol; 1984 Feb; 49(2):598-600. PubMed ID: 6319762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical mapping of paar mutations of herpes simplex virus type 1 and type 2 by intertypic marker rescue.
    Chartrand P; Stow ND; Timbury MC; Wilkie NM
    J Virol; 1979 Aug; 31(2):265-76. PubMed ID: 225553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The herpes simplex virus type 1 DNA polymerase gene: site of phosphonoacetic acid resistance mutation in strain Angelotti is highly conserved.
    Knopf CW
    J Gen Virol; 1987 May; 68 ( Pt 5)():1429-33. PubMed ID: 3033142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of herpes simplex virus to adenine arabinoside and E-5-(2-bromovinyl)-2'-deoxyuridine: a physical analysis.
    Crumpacker CS; Schnipper LE; Kowalsky PN; Sherman DM
    J Infect Dis; 1982 Aug; 146(2):167-72. PubMed ID: 6286786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-resistant mutants of herpes simplex virus type 2 with a mutator or antimutator phenotype.
    Nishiyama Y; Yoshida S; Tsurumi T; Yamamoto N; Maeno K
    Microbiol Immunol; 1985; 29(4):377-81. PubMed ID: 2991710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.